| Code | 1492C | ||||||||||
| MA number | 31/0467/16-S | ||||||||||
| Product Form: | tbl 60x1x10 mg (blis.OPA/Al/PVC/Al-jednotliv.bal.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.10.2016 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Ezoleta 10 mg tablety_12.2023.pdf
|
| PIL: |
PIL_Ezoleta 10 mg tablety_12.2023.pdf
|
| Safety feature | Yes |
| Data update: | 22.09.2022 |
